Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial.

por Sweeney, P. J., Nicolae, D., Ignacio, L., Chen, L., Roach, M., Wara, W., Marcus, K. C., Vijayakumar, S.
Publicado 1998